Company Encyclopedia
View More
name
Acrux Limited
ACR.AU
News
View More

Acrux Limited Announces Quotation of New Securities on ASX

Acrux Limited has announced the quotation of 448,334 ordinary fully paid securities on the Australian Securities Exchange (ASX) effective May 23, 2025. This follows the lifting of transfer restrictions on securities from an employee incentive scheme, aiming to enhance market liquidity and provide more investment opportunities for stakeholders. Acrux's current market cap stands at A$9.78M with an average trading volume of 271,212.

Tip Ranks·
Tip Ranks·

Acrux Limited Announces Registry Office Relocation

Acrux Limited (AU:ACR) has announced the relocation of its registry office in Sydney, effective April 14, 2025. The new address will be Liberty Place, Level 41, 161 Castlereagh St, Sydney, managed by MUFG Corporate Markets (AU) Limited. This operational change does not affect contact details. Acrux Limited specializes in developing and commercializing topical pharmaceutical products and has a market cap of $5.39M with a year-to-date price performance of 33.33%.

Tip Ranks·
Tip Ranks·

Acrux Limited Highlights Future Prospects in Topical Pharmaceuticals

Acrux Limited (AU:ACR) has announced its focus on developing and commercializing topical pharmaceuticals through an investor presentation. The presentation outlines forward-looking statements regarding the company's future performance, acknowledging uncertainties and risks influenced by economic conditions, resource availability, regulatory actions, and competition. Acrux Limited is a specialty pharmaceutical company with a current market cap of $7.77M and a consensus rating of 'Buy'.

Tip Ranks·
Tip Ranks·

Acrux Releases Top 20 Option Holders and Distribution Schedule

Acrux Limited (AU:ACR) has announced the release of its top 20 option holders and distribution schedule for a new class of quoted securities, following its Appendix 2A Application. This update, based on the Options Prospectus dated January 17, 2025, reflects Acrux's commitment to enhancing its financial operations and market presence. The pharmaceutical company, with over 25 years of experience, focuses on developing topical pharmaceuticals and is positioned for partnerships and product development. Current market cap stands at $8.24M.

Tip Ranks·
Tip Ranks·

Acrux Limited Announces Director’s Interest Change

Acrux Limited (AU:ACR) has announced a change in director's interest, specifically regarding Director Tim Oldham, who acquired 285,714 free attaching options. This change was approved at the Extraordinary General Meeting on February 3, 2025, and may impact the company's operational strategies and stakeholders due to the increased securities holdings of a key director. The current market cap of Acrux Limited is $8.24M, with a consensus rating of 'Buy'.

Tip Ranks·
Tip Ranks·